​
​

Rocket Pharmaceuticals (RCKT) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Rocket Pharmaceuticals Revenue Highlights

00

Rocket Pharmaceuticals Revenue by Period

Rocket Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31--

Rocket Pharmaceuticals generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Rocket Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$10.31M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31--

Rocket Pharmaceuticals generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Rocket Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MIRMMirum Pharmaceuticals$186.37M$77.88M
STROSutro Biopharma$153.73M$25.71M
RGNXREGENXBIO$90.24M$24.20M
RYTMRhythm Pharmaceuticals$77.43M$29.08M
MRUSMerus$43.95M$11.77M
QUREuniQure$15.84M$2.29M
MGTXMeiraGTx$14.02M$10.91M
RVMDRevolution Medicines, Inc. Warrant$11.58M-
STOKStoke Therapeutics$8.78M$4.89M
CYTKCytokinetics$7.53M$463.00K
PLRXPliant Therapeutics$1.58M-
VRDNViridian Therapeutics$314.00K$86.00K
PCVXVaxcyte--
DAWNDay One Biopharmaceuticals-$20.07M
INZYInozyme Pharma--
DYNDyne Therapeutics--
REPLReplimune Group--
RCKTRocket Pharmaceuticals--
SNDXSyndax Pharmaceuticals-$12.50M
LRMRLarimar Therapeutics--
SLDBSolid Biosciences--

RCKT Revenue FAQ

What is Rocket Pharmaceuticals’s yearly revenue?

Rocket Pharmaceuticals's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. RCKT's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Rocket Pharmaceuticals’s quarterly revenue?

Rocket Pharmaceuticals's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). RCKT's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is Rocket Pharmaceuticals’s revenue growth rate?

Rocket Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.